Application of Chromatography. XXXIII. V-Compound Isolated from the Mycelium of Eremothecium ashbyii.
スポンサーリンク
概要
- 論文の詳細を見る
The purple fluorescent substance (V-compound) obtained by the authors from the mycelium of Er. ashbyii occurs as colorless needles, m. p. 263°(decomp.), [α]^<20>_D : +4.5°(in H_<2O>), +11.45°(in 0.1N NaOH). The molecular weight of this substance was found to be about 300 by Barger method, titration (as monobasic acid), and from the wave height in polarography. A molecular formula of C_<12>H_<16>O_7N_4 was assigned to the substance from its analytical value. From its ultraviolet and infrared spectra the presence of a pteridine ring, COOH, and OH was presumed. Since the substance gave urea by treatment with alkali solution, it was assumed to be a pteridine compound having a carbonyl group at 2-position, substituted by a group at one of the nitrogens in the pyrazine ring. From the fact that the acetylation product of the substance was in accord with its tetraacetate, and that it gave formaldehyde by oxidation with lead tetraacetate, the group was presumed to be ribityl. Photodecomposition of this substance furnished more important data. Although exposure of an aqueous solution of the substance to direct sunlight destroyed even the pteridine ring, irradiation of its alkaline solution with light from an electric lamp in the presence of hydrogen peroxide yielded crystals of m. p. >360°. The product exhibited the ultraviolet spectrum characteristic to pteridine compounds. Comparison of the product with lumazine-6-carboxylic acid by ionophoresis indicated that the former has lower negative charge than the latter. Therefore, the molecular formula, C_7H_6O_4N_4,calculated from the analytical value was concluded to be C_7H_4O_3N_4・H_2O. This may be due to the dehydrogenation of the parent ring during cleavage of the group at the nitrogen of the pyrazine ring by photodecomposition of the V-compound. From these results, the authors gave the following structure to the V-compound.
- 公益社団法人日本薬学会の論文
- 1957-12-20
著者
-
浅井 満子
Research Laboratories, Takeda Chemical Industries., Ltd.
-
増田 亨
Research Laboratories, Takeda Chemical Industries, Ltd.
-
貴志 豊和
Research Laboratories, Takeda Pharmaceutical Industries, Ltd.
-
増田 亨
Research Laboratories Takeda Pharmaceutical Industries Ltd.
-
浅井 満子
武田薬品中研
-
貴志 豊和
武田薬品研究所
関連論文
- Application of Chromatography. XLV. On the Mechanism of Biosynthesis of 6-Methyl-7-hydroxyribolumazine.
- On the Mechanism of Biosynthesis of 6-Methyl-7-hydroxyribolumazine
- Application of Chromatography. XLIII. On the Mechanism of Enzymic Conversion of 6,7-Dimethylribolumazine to Riboflavin.
- Application of Chromatography. XLII. Formation of Riboflavin by Enzyme System from Leuco-type Strain of Eremothecium ashbyii.
- On the Mechanism of Enzymic Conversion of 6,7-Dimethylribolumazine to Riboflavin
- Application of Chromatography. XLI. Behavior of Diaminouracil Derivatives.
- Application of Chromatography. XL. Riboflavin-activity of 6,7-Dimethylribolumazine in Animal Body
- Application of Chromatography. XXXIX. Biosynthesis of Riboflavin. (3).
- Application of Chromatography. XXXVIII. Total Synthesis of 6-Methyl-7-hydroxyribolumazine.
- Application of Chromatography. XXXVII. Total Synthesis of 6,7-Dimethylribolumazine.
- Application of Chromatography. XXXVI. Biosynthesis of Riboflavin. (2). Riboflavin-synthesizing Enzyme extracted from Eremothecium ashbyii.
- Application of Chromatography. XXXV. On the Biochemical Significance of 6-Methyl-7-hydroxyribolumazine in the Culture of Eremothecium ashbyii.
- On the Nomenclature of the Fluorescent Substances produced in the Culture of Eremothecium ashbyii
- 71.Eremothecium ashbyiiの生産するV化合物(6-Methyl-7-hydroxy-ribolumazine)の生成機構(第10回大会研究発表要旨)
- 6.V物質の構造(第99回協議会研究発表要旨)
- 2.Eremothecium ashbyiiの生産するV物質の構造(第96回協議会研究発表要旨)
- Enduracidin, a New Antibiotic. VIII. Structures of Enduracidins A and B
- Studies on Pillaromycin A. IV. The Structure of Pillaromycin A
- 51 新抗腫瘍性抗生物質Macbecin I及びIIの構造
- The Structure of Aristeromycin
- X-Ray Analysis of an Unusual Amino Acid Isolated from the Hydrolysate of a New Antibiotic, Enduracidin
- 63 新カルバペネム系抗生物質C-19393の化学
- 3 新抗生物貭Tolypomycinの構造
- Application of Chromatography. XXXIV. Structure of the Purple Fluorescent Substance produced by Eremothecium ashbyii.
- Structure of V-Compound produced by Eremothecium Ashbyii
- Application of Chromatography. XXXIII. V-Compound Isolated from the Mycelium of Eremothecium ashbyii.
- Synthesis of Polyhydroxysteroids. V. Preparation and Infrared Spectra of 16β, 20α-Isopropylidenedioxysteroids.
- Synthesis of Polyhydroxy-steroids. II. Syntheses of Isomeric 5α-Pregnane-3,5,6,16,20-pentols and Related Compounds.
- Maridomycin, a New Macrolide Antibiotic. XI. The Structures of Maridomycin Components
- Maridomycin, a New Macrolide Antibiotic. X. The Structure of Maridomycin II
- Maridomycin, a New Macrolide Antibiotic. XII. A Simple Quantitative Analysis of 9-Propionylmaridomycin Components
- 16 新核酸系抗生物質Mildiomycinの化学構造
- Studies on Lankacidin-Group (T-2636) Antibiotics. V. Chemical Structures of Lankacidin-Group Antibiotics. (1)
- The Absolute Configuration of P-1894B, A Potent Prolyl Hydroxylase Inhibitor
- Stereochemical Interrelationship between Maridomycin and Leucomycin
- 19.Alstonia alkaloid "Macralstonine"の構造研究
- Action of Enzyme from Eremothecium ashbyii upon 6-Methyl-7-(2-hydroxy-2-methyl-3-oxobutyl) ribolumazine
- クロマトグラフィーの応用(第27報)Eremothecium ashbyiiの培養におけるFADの生成
- クロマトグラフィーの応用(第22報)インシュリン製品の化学的検定法
- クロマトグラフィーの応用(第20報) : コカルボキシラーゼ製品の定量的検定法
- Application of Chromatography. XXXII. Biosynthesis of Riboflavin by Eremothecium ashbyii.
- Application of Chromatography. XXXI. Structure of a Green Fluorescent Substance produced by Eremothecium ashbyii.
- Eremothecium ashbyiiの培養におけるトリプトファン代謝(クロマトグラフィーの応用 第30報)
- Eremothecium ashbyiiの菌体から分離されたG化合物(クロマトグラフィーの応用 第29報)
- Deuterated Riboflavinの赤外部吸収スペクトルについて
- Eremothecium ashbyiiの生産する新物質の単離
- Eremothecium ashbyiiの生産する緑色蛍光物質の単離
- Eremothecium ashbyiiの培養におけるFADの生成機構(クロマトグラフィーの応用第28報)